OptiNose US, Inc.

ACTIVE

777 Township Line Rd Ste 300, 宾夕法尼亚州费拉德尔菲亚县, Pennsylvania, United Stateswww.optinose.comSubsidiary

Part of OptiNose

Clinical Trials

8 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

100.0%

Trial Status Distribution

Active, not recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (8)

A 24-week study to find out if the nasal spray containing fluticasonepropionate administered twice a day provides improvement and is safe forpatients suffering from chronic sinusitis without nasal polyps.

Phase 1

Active, not recruiting

Mar 2022399 participants

A 24-week study to find out if the nasal spray containing fluticasone propionate administered twice a day provides improvement and is safe for patients suffering from chronic rhinosinusitis, and with or without nasal polyps.

Phase 1

Active, not recruiting

Nov 2020333 participants

A 24-week study to find out if the nasal spray containing fluticasonepropionate administered twice a day provides improvement and is safe for patients suffering from chronic rhinosinusitis without nasal polyps.

Phase 1

Active, not recruiting

Nov 2020210 participants

A 24-week study to find out if the nasal spray containing fluticasone propionate administered twice a day provides improvement and is safe for patients suffering from chronic sinusitis without nasal polyps.

Phase 1

Active, not recruiting

Jul 2019399 participants

A 24-week study to find out if the nasal spray containing fluticasonepropionate administered twice a day provides improvement and is safe forpatients suffering from chronic rhinosinusitis without nasal polyps.

Phase 1

Active, not recruiting

Jun 2019210 participants

A 24-week study to find out if the nasal spray containing fluticasonepropionate administered twice a day provides improvement and is safe for patients suffering from chronic rhinosinusitis without nasal polyps.

Phase 1

Active, not recruiting

May 2019210 participants

A 24-week study to find out if the nasal spray containing fluticasonepropionate administered twice a day provides improvement and is safe for patients suffering from chronic rhinosinusitis without nasal polyps.

Phase 1

Active, not recruiting

Apr 2019399 participants

A 24-week study to find out if the nasal spray containing fluticasone propionate administered twice a day provides improvement and is safe for patients suffering from chronic sinusitis, and with or without nasal polyps.

Phase 1

Active, not recruiting

Apr 2019378 participants

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations